Home
October 2008 November 2008 December 2008
Su Mo Tu We Th Fr Sa
Week 44 1
Week 45 2 3 4 5 6 7 8
Week 46 9 10 11 12 13 14 15
Week 47 16 17 18 19 20 21 22
Week 48 23 24 25 26 27 28 29
Week 49 30

Treatment Show Comments PDF Print E-mail
  
Thursday, 06 April 2006

Recommended Regimens
Azithromycin 1 g orally in a single dose,
     OR
Ceftriaxone 250 mg intramuscularly (IM) in a single dose,
     OR
Ciprofloxacin 500 mg orally twice a day for 3 days,
     OR
Erythromycin base 500 mg orally three times a day for 7 days.

  • NOTE: Ciprofloxacin is contraindicated for pregnant and lactating women.
  • Azithromycin and ceftriaxone offer the advantage of single-dose therapy
  • Worldwide, several isolates with intermediate resistance to either ciprofloxacin or erythromycin have been reported.

Follow-Up

  • Patients should be re-examined 3--7 days after initiation of therapy
  • If no clinical improvement is evident, the clinician must consider whether
    • The diagnosis is correct
    • The patient is coinfected with another STD
    • The patient is infected with HIV
    • The treatment was not used as instructed
    • The H. ducreyi strain causing the infection is resistant to the prescribed antimicrobial

References

Sexually Transmitted Diseases
Treatment Guidelines 2002
MMWR
Morbidity and Mortality Weekly Report
Recommendation and Reports
May 10, 2002/Vol. 51/No.RR-6

 

Reader Comments

Please log-in or register in order to submit comments.

Powered by AkoComment!

 
User Rating: / 0
PoorBest